This website uses cookies, including third party ones, to allow for analysis of how people use our website in order to improve your experience and our services. By continuing to use our website, you agree to the use of such cookies. Click here for more information on our and .
Earlier this year, Austrade released the new Clinical Trials industry capability report which highlights why Australia is a leading destination for clinical research of new therapeutic products and medical devices.
The report showcases Australia’s strengths in the sector—world-class medical research infrastructure, an efficient regulatory system, a strong and stable business environment, and generous tax incentives—that make it an attractive and competitive location for clinical trials.
For more details on on why Australia is an ideal destination for clinical trials, download the full report from the Austrade website here
